Kota Kakeshita
Overview
Explore the profile of Kota Kakeshita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kakeshita K, Imamura T, Hida Y, Onoda H, Koike T, Kinugawa K
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768446
Even in current guideline-directed medical therapy, including recently introduced vasopressin type 2 receptor antagonist tolvaptan, congestion has not been resolved in patients with heart failure. Kampo medicine goreisan has been...
2.
Hida Y, Imamura T, Onoda H, Kakeshita K, Kinugawa K
Heart Vessels
. 2024 Jun;
39(12):1029-1035.
PMID: 38904671
We often encounter patients with congestive heart failure refractory to conventional diuretics therapy. Kampo goreisan (Tsumura &Co. Tokyo, Japan) is receiving great concern in mediating body water balance, particularly for...
3.
Marubayashi N, Kakeshita K, Imamura T
Clin Cardiol
. 2024 May;
47(5):e24279.
PMID: 38775272
No abstract available.
4.
Yokoyama S, Kakeshita K, Imamura T, Shima T, Fujioka H, Yamazaki H, et al.
Intern Med
. 2024 Mar;
63(20):2839-2845.
PMID: 38462521
Pegylated liposomal doxorubicin (PLD) has emerged as a recent innovation within the realm of antineoplastic agents, distinguished by its incorporation of doxorubicin within the liposomal bilayer. Given the low risk...
5.
Izumida T, Imamura T, Nakagaito M, Onoda H, Tanaka S, Ushijima R, et al.
Int Heart J
. 2023 Oct;
64(5):865-869.
PMID: 37778989
Remote dielectric sensing (ReDS) is a non-invasive, electromagnetic energy-based technology to quantify pulmonary congestion. However, the accuracy of ReDS values in patients with a variety of physiques has not been...
6.
Kakeshita K, Imamura T, Noguchi A, Murai S, Fujioka H, Yamazaki H, et al.
CEN Case Rep
. 2023 Sep;
13(3):154-160.
PMID: 37737334
Takayasu arteritis is a rare, chronic, and large-vessel vasculitis involving the aorta and its branches in a complex autoimmune reaction. Takayasu arteritis sometimes complicates aortic regurgitation and chronic kidney disease,...
7.
Fujioka H, Kakeshita K, Imamura T, Arisawa Y, Yokoyama S, Yamazaki H, et al.
Intern Med
. 2023 Jun;
63(4):533-539.
PMID: 37380456
Pembrolizumab, an immune checkpoint inhibitor, is used to treat a variety of refractory malignancies. However, these agents are sometimes associated with immune-related adverse events. A 71-year-old woman received pembrolizumab-integrated chemotherapy...
8.
Fujioka H, Koike T, Imamura T, Kakeshita K, Yamazaki H, Kinugawa K
Clin Exp Nephrol
. 2023 Apr;
27(7):613-621.
PMID: 37095344
Background: Obesity is associated with the development and progression of chronic kidney disease (CKD). In the general population, the amount of renal sinus fat was associated with hypertension and renal...
9.
Kobayashi S, Yamazaki H, Imamura T, Fujioka H, Kakeshita K, Koike T, et al.
Int Urol Nephrol
. 2023 Apr;
55(11):2935-2941.
PMID: 37010737
Background: The synthesis of growth differentiation factor-15 (GDF-15) is induced by inflammation, hypoxia, and oxidative stress and is receiving great interest as a predictive biomarker for cardiovascular disease. However, its...
10.
Kakeshita K, Koike T, Imamura T, Fujioka H, Yamazaki H, Kinugawa K
Clin Exp Nephrol
. 2023 Feb;
27(5):427-434.
PMID: 36752971
Background: The clinical utility of tolvaptan in chronic kidney disease (CKD) patients with heart failure remains uncertain. The level of urine cyclic adenosine monophosphate (AMP) relative to plasma arginine vasopressin...